Medgend Icon

Ledgend of Medicine







discontinued


Rubraca FDA Approved Drugs

RUBRACA [Rucaparib CamsylateC19H18FN3OC10H16O4S]
RX
-
eq 200mg base (oral tablet)
eq 250mg base (oral tablet)
eq 300mg base (oral tablet)
Clovis Oncology IncDec 19, 2016
  • A method for treating ovarian cancer by administering rucaparib, wherein the cancer is associated with a deleterious brca mutation.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.